Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial

Behazine Combadière, Annika Vogt, Brice Mahé et al. · 2010

Read Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial by Behazine Combadière, Annika Vogt, Brice Mahé et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010818.txt.

Description

Behazine Combadière and colleagues ran an early human trial of a needle-free flu vaccine, in PLOS ONE in 2010. Standard flu shots train antibodies well but raise weak killer T cell responses. Killer CD8 cells matter most against new flu strains that antibodies miss. The skin is rich in immune sentinels, and hair follicles offer a route in.

Volunteers received inactivated flu vaccine through the skin in a randomized phase I trial. The skin route preferentially amplified CD8 effector T cells. That bias is exactly what flu vaccinology has been missing. A safe, needle-free patch that trains killer cells could change both yearly flu shots and pandemic response.

Catalog record

CREATORBehazine Combadière, Annika Vogt, Brice Mahé et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010818

Browse the full library · About the Tower of Babel